Entity Details
| Primary name |
HPS5_HUMAN |
| Entity type |
UniProt |
| Source |
Source Link |
Details
| Accession | Q9UPZ3 |
| EntryName | HPS5_HUMAN |
| FullName | Hermansky-Pudlak syndrome 5 protein |
| TaxID | 9606 |
| Evidence | evidence at protein level |
| Length | 1129 |
| SequenceStatus | complete |
| DateCreated | 2001-02-21 |
| DateModified | 2021-06-02 |
Subcellular Location
Show/Hide Table
| Subcellular Location |
| Cytoplasm |
Domains
Show/Hide Table
| Domain | Name | Category | Type |
| IPR015943 | WD40/YVTN repeat-like-containing domain superfamily | Family | Homologous superfamily |
| IPR035431 | Hermansky-Pudlak syndrome 5 protein | Family | Family |
| IPR036322 | WD40-repeat-containing domain superfamily | Family | Homologous superfamily |
Diseases
Show/Hide Table
| Disease ID | Source | Name | Description |
| 614074 | OMIM | Hermansky-Pudlak syndrome 5 (HPS5) | A form of Hermansky-Pudlak syndrome, a genetically heterogeneous autosomal recessive disorder characterized by oculocutaneous albinism, bleeding due to platelet storage pool deficiency, and lysosomal storage defects. This syndrome results from defects of diverse cytoplasmic organelles including melanosomes, platelet dense granules and lysosomes. Ceroid storage in the lungs is associated with pulmonary fibrosis, a common cause of premature death in individuals with HPS. The disease is caused by variants affecting the gene represented in this entry. |
Interactions
2 interactions